Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.910
-0.020 (-1.04%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Akebia Therapeutics Employees
Akebia Therapeutics had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.
Employees
181
Change (1Y)
14
Growth (1Y)
8.38%
Revenue / Employee
$884,972
Profits / Employee
-$383,481
Market Cap
451.20M
Employees Chart
AKBA News
- 3 days ago - Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - GlobeNewsWire
- 8 days ago - JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
- 8 days ago - Akebia Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 9 days ago - Akebia Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 15 days ago - Akebia Therapeutics, Inc. (AKBA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Akebia Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Vafseo® (vadadustat) Commercial Launch Progress Update - GlobeNewsWire
- 22 days ago - Akebia Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Discuss Recent Business Highlights - GlobeNewsWire
- 23 days ago - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire